Literature DB >> 10343131

Evidence for decreased salivary function in patients with reflux esophagitis.

C H Kao1, Y J Ho, S P ChangLai, K K Liao.   

Abstract

It has been speculated that impaired salivary flow contributes to abnormal acid clearance of the esophagus in gastroesophageal reflux and results in reflux esophagitis (RE). To test this hypothesis, salivary functions were measured by quantitative salivary scintigraphies in patients with RE and in age- and sex-matched controls for comparison. Nineteen patients with RE and 36 healthy volunteers were enrolled in the study. After an intravenous injection of 5 mCi Tc-99m pertechnetate, sequential images of 1 min/frame were acquired for 30 min. The 1- and 15-min uptake ratios (UR) of the tracer in the four major salivary glands over the backgrounds were calculated. Saliva excretion was stimulated by 1 tablet of 200 mg ascorbic acid given orally 15 min after injection of the tracer, then the maximal excretion ratios (ER) of the four major salivary glands were calculated for the sialagogue stimulation. RE patients had lower values of 1st and 15th min UR and maximal ER than controls in the 4 major salivary glands. Poor salivary functions which represented a decrease in both UR and ER for patients with RE have been confirmed by quantitative salivary scintigraphy in this study.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10343131     DOI: 10.1159/000007658

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  7 in total

1.  Nizatidine and cisapride increase salivary secretion in rats.

Authors:  Kyoichi Adachi; Kenji Furuta; Tomoko Katsube; Tomoo Fujisawa; Takane Azumi; Hirofumi Fujishiro; Shunji Ishihara; Yuji Amano; Yoshikazu Kinoshita
Journal:  Dig Dis Sci       Date:  2004-03       Impact factor: 3.199

2.  Stimulated saliva secretion is reduced in proton pump inhibitor-resistant severe reflux esophagitis patients.

Authors:  Tomohide Tanabe; Mai Koeda; Yuichi Kitasako; Eri Momma; Yoshimasa Hoshikawa; Shintaro Hoshino; Noriyuki Kawami; Mitsuru Kaise; Katsuhiko Iwakiri
Journal:  Esophagus       Date:  2021-02-15       Impact factor: 4.230

3.  Rebamipide and mosapride enhance pilocarpine-induced salivation.

Authors:  Yoshihisa Urita; Toshiyasu Watanabe; Tadashi Maeda; Yosuke Sasaki; Kazuo Hike; Hiroshi Muto; Masaki Sanaka; Nagato Shimada; Hitoshi Nakajima; Motonobu Sugimoto
Journal:  N Am J Med Sci       Date:  2009-08

4.  Erosive esophageal reflux vs. non erosive esophageal reflux: oral findings in 71 patients.

Authors:  Herbert Deppe; Thomas Mücke; Stefan Wagenpfeil; Marco Kesting; Anna Rozej; Monther Bajbouj; Anton Sculean
Journal:  BMC Oral Health       Date:  2015-07-25       Impact factor: 2.757

5.  Nizatidine Improves Impaired Salivary Secretion in GERD.

Authors:  Yoshihisa Urita; Toshiyasu Watanabe; Kazuo Hike; Makie Nanami; Tadashi Maeda; Yosuke Sasaki; Asuka Nakayama; Takamasa Ishii; Kaoru Domon; Susumu Ishihara; Masaki Sanaka; Hitoshi Nakajima; Motonobu Sugimoto
Journal:  Clin Med Case Rep       Date:  2008-08-19

6.  Risk factors associated with oral manifestations and oral health impact of gastro-oesophageal reflux disease: a multicentre, cross-sectional study in Pakistan.

Authors:  Ibrahim Warsi; Javeria Ahmed; Anjum Younus; Abdur Rasheed; Tayyab Saeed Akhtar; Qurrat Ul Ain; Zohaib Khurshid
Journal:  BMJ Open       Date:  2019-03-30       Impact factor: 2.692

7.  The relationship between gastroesophageal reflux disease and chronic periodontitis.

Authors:  Jun Young Song; Hyung Hun Kim; Eun Ju Cho; Tae Yun Kim
Journal:  Gut Liver       Date:  2013-11-05       Impact factor: 4.519

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.